$4568 (+0,26%) together with $AZN (-2,23%) is currently developing the drug Datroway (breast cancer). Sales revenues of around € 6 billion are expected by 2030:
What do you think of the share? There is still a dividend and the share price has been down 30% for a year. Irritates me a little. Any opinions?
